Shockwave Medical, Inc.
SWAVDelisted May 31, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001642545
Shockwave Medical, Inc. was delisted on May 31, 2024; its insiders filed their last Form 4 on May 31, 2024; 486 institutions reported holding it in 13F filings for Q1 2024, worth $12.0B in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Shockwave Medical, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
SWAV is no longer listed, and 13F filings after Q1 2024 list far fewer holders. See Q1 2024
- Institutional holders
- 7
- −474 vs. Q1 2024
- Shares held
- 6.24K
- −36.6M (−100.0%) vs. Q1 2024
- Total value
- $1.93M
- −$11.9B (−100.0%) vs. Q1 2024
- New holders
- 1
- 2 more added
- Sold out
- 475
- 3 more reduced
5 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SWAV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 2 | $276.1K |
| Q2 2024 | 7 | $1.93M |
| Q1 2024 | 486 | $12.0B |
| Q4 2023 | 427 | $6.76B |
| Q3 2023 | 413 | $6.85B |
| Q2 2023 | 460 | $9.33B |
| Q1 2023 | 382 | $7.31B |
| Q4 2022 | 415 | $6.66B |
| Q3 2022 | 411 | $9.23B |
| Q2 2022 | 337 | $6.63B |
| Q1 2022 | 308 | $6.67B |
| Q4 2021 | 294 | $5.65B |
| Q3 2021 | 267 | $6.64B |
| Q2 2021 | 240 | $6.11B |
| Q1 2021 | 217 | $4.24B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Shockwave Medical, Inc.; share changes are against Q1 2024.